Perspective Regulatory Framework on Health Claim of Tea-Mini Review

This review aims to explain the position of tea products based on the perspective of the regulatory framework of food health claims in the different official agencies in the United States, Europe, and Japan

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Tea is a popular beverage with potential health benefits for those who consume it regularly.

📊

Key Findings & Data:Tea products with health claims require scientific evidence based on clinical trials with generally accepted scientific data and newly developed scientific data.

💡

Conclusion & Impact:This review aims to explain the position of tea products based on the perspective of the regulatory framework of food health claims in the different official agencies in the United States, Europe, and Japan

🔬Design:Review & Systematic Survey

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Tea is a popular beverage with potential health benefits for those who consume it regularly. Tea products with health claims require scientific evidence based on clinical trials with generally accepted scientific data and newly developed scientific data. Tea products have been labelled FOSHU in Japan, claiming to reduce body fat and cardiovascular risk. In The USA, health claims on tea cannot be recommended and categorized as Qualified Health Claims. In Europe, health claims for tea still required further research to provide accepted scientific data. This review aims to explain the position of tea products based on the perspective of the regulatory framework of food health claims in the different official agencies in the United States, Europe, and Japan

🔖

Cite This Article

Setyaningtyas, S. W., Priatni, S., Sulaswatty, A., Setiadi, D., Prawira-Atmaja, M. I., Sita, K., Maulana, H. (2022). Perspective Regulatory Framework on Health Claim of Tea-Mini Review. Türk Tarım - Gıda Bilim ve Teknoloji dergisi, Cilt: 10 - Sayı: 4, 555–561. https://ajindex.com/articles/642478

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Arai S. 2000. ‘Functional food science in Japan: State of the art’, BioFactors, 12(1-4): 13–16. doi: 10.1002/biof.5520120103. Berhaupt-Glickstein A. et al. 2014. ‘The evolution of language complexity in qualified health claims’, Food Policy, 47:62-70. doi: 10.1016/j.foodpol.2014.04.005. Berhaupt-Glickstein A, Hooker NH, Hallman WK. 2019. ‘Qualified health claim language affects purchase intentions for green tea products in the united states’, Nutrients, 11(4). doi: 10.3390/nu11040921. Bo’ et al. 2019. ‘Systematic Review on Polyphenol Intake and Health Outcomes: Is there Sufficient Evidence to Define a Health-Promoting Polyphenol-Rich Dietary Pattern?’, Nutrients, 11(6): 1355. doi: 10.3390/nu11061355. De Boer A, Bast A. 2015. ‘International legislation on nutrition and health claims’, Food Policy, 55: 61-70. doi: 10.1016/j.foodpol.2015.06.002. Codex A. 2009. ‘General guidelines on claims’, CAC/GL 1-1979, (Adopted 1979. Revised 1991. Amended 2009). Codex A. 2013. ‘Guidelines for use of nutrition and health claims’, CAC/GL 23-1997, (Adopted in 1997. Revised in 2004. Amended in 2001, 2008, 2009, 2010, 2011, 2012 and 2013. Annex adopted 2009). Dekant W. et al. 2017. ‘Safety assessment of green tea-based beverages and dried green tea extracts as nutritional supplements’, Toxicology Letters, 277(June): 104-108. doi: 10.1016/j.toxlet.2017.06.008. EFSA Panel on Dietetic Products N. and A. (NDA) 2008. ‘Black tea from Camellia sinensis and helps to focus attention - Scientific substantiation of a health claim related to black tea from Camellia sinensis and helps to focus attention, pursuant to Article 13(5) of Regulation (EC) No 1924/2006’, EFSA Journal, 6(12): 906. doi: 10.2903/j.efsa.2008.906. EFSA Panel on Dietetic Products, N. and A. (NDA) (2010a). ‘Scientific Opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins from green tea, and contribution to the maintenance or achievement of a normal body weight (ID 1107, 1112, 1544, 2716), increased’, EFSA Journal, 8(10): 1791. doi: 10.2903/j.efsa.2010.1791. EFSA Panel on Dietetic Products N. and A. (NDA) (2010b). ‘Scientific Opinion on the substantiation of health claims related to Camellia sinensis (L.) Kuntze (tea), including catechins in green tea and tannins in black tea, and protection of DNA, proteins and lipids from oxidative damage (ID 1103, 1276, 1311, 170’, EFSA Journal, 8(2): 1463. doi: 10.2903/j.efsa.2010.1463. EFSA Panel on Dietetic Products N. and